What are the major opportunities in the Geographic Atrophy market? What are the strategies for the Geographic Atrophy market?

For detailed insights on the major opportunities and strategies in the Geographic Atrophy market, Read More

How does the Geographic Atrophy market relate to the overall economy and other similar markets?

For detailed insights on Geographic Atrophy's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Geographic Atrophy market growth? SWOT analysis of the Geographic Atrophy market.

For detailed insights on the key dynamics influencing the Geographic Atrophy market growth and SWOT analysis of the Geographic Atrophy industry, Read More

Geographic Atrophy Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Geographic Atrophy Market Report 2026

Name: Geographic Atrophy Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Type (Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, Complement Inhibitors, Neuroprotective Agents, Other Drug Types), By Diagnosis (Fundus Autofluorescence (FAF), Optical Coherence Tomography Angiography (OCT-A), Multifocal Electroretinography (mfERG)), By Route Of Administration (Intravitreal, Oral, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Geographic Atrophy Market Overview

• Geographic Atrophy market size has reached to $2.11 billion in 2025

• Expected to grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%

• Growth Driver: Rising Prevalence Of Age-Related Macular Degeneration Driving Geographic Atrophy Market Growth Due To Aging Population Trends

• Market Trend: Innovative Complement Inhibitor Therapy Advancing Treatment Options For Progressive Eye Disease

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Geographic Atrophy Market?

Geographic atrophy is an eye condition that causes gradual vision loss due to damage in the retina. It is a severe form of age-related macular degeneration (AMD) that leads to blind spots in central vision.

The main drug types of geographic atrophy are anti-vascular endothelial growth factor (VEGF) therapy, complement inhibitors, neuroprotective agents, others. Complement inhibitors are treatments that regulate an overactive immune response by blocking specific proteins involved in inflammation and cell damage. The various diagnosis includes fundus autofluorescence (FAF), optical coherence tomography angiography (OCT-A), multifocal electroretinography (mfERG). These are administered through various route of administration such as intravitreal, oral, other routes of administration and are distributed through various distribution channels such as hospital pharmacies, retail pharmacies, online pharmacies, others.

Geographic Atrophy Market Global Report 2026 Market Report bar graph

What Is The Geographic Atrophy Market Size and Share 2026?

The geographic atrophy market size has grown rapidly in recent years. It will grow from $2.11 billion in 2025 to $2.4 billion in 2026 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to aging population growth, prevalence of age-related macular degeneration, advances in retinal imaging, early ophthalmic drug development, clinical research funding.

What Is The Geographic Atrophy Market Growth Forecast?

The geographic atrophy market size is expected to see rapid growth in the next few years. It will grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to approval of novel therapies, expansion of screening programs, integration of ai-based imaging, increased patient awareness, growth of specialty eye care. Major trends in the forecast period include rising development of complement inhibitor therapies, growing focus on early diagnosis of retinal disorders, increased investment in novel ophthalmic drugs, expansion of imaging technologies for disease monitoring, growing clinical trials for amd treatments.

Book your 30 minutes free consultation with our research experts

Global Geographic Atrophy Market Segmentation

1) By Drug Type: Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, Complement Inhibitors, Neuroprotective Agents, Other Drug Types

2) By Diagnosis: Fundus Autofluorescence (FAF), Optical Coherence Tomography Angiography (OCT-A), Multifocal Electroretinography (mfERG)

3) By Route Of Administration: Intravitreal, Oral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:

1) By Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: Ranibizumab, Aflibercept, Bevacizumab

2) By Complement Inhibitors: Pegcetacoplan, Lfg316

3) By Neuroprotective Agents: Latanoprost, Brimonidine

4) By Other Drug Types: Steroids, Retinoids, Combination Therapy

What Is The Driver Of The Geographic Atrophy Market?

Increasing prevalence of age-related macular degeneration is expected to propel the growth of the geographic atrophy market going forward. Age-related macular degeneration (AMD) is an eye condition that damages the central part of the retina of the older adults, making it difficult to see fine details. Aging population is the major reason for the prevalence of age-related macular degeneration, as more people are living longer, and the natural aging process causes gradual damage to the eyes, making them more vulnerable to the disease over time. Geographic atrophy treatment support age-related macular degeneration (AMD) patients by slowing the progression of retinal damage and preserving remaining vision. For instance, in January 2024, according to a report published by Medical News Today, a US-based digital media company, the global cases of age-related macular degeneration are expected to rise from 196 million to 288 million by 2040. Therefore, the increasing prevalence of age-related macular degeneration is driving the growth of the geographic atrophy industry.

Key Players In The Global Geographic Atrophy Market

Major companies operating in the geographic atrophy market are Regeneron Pharmaceuticals Inc, Ocugen Inc, Kodiak Sciences Inc, Apellis Pharmaceuticals Inc, Iveric Bio, Graybug Vision, SparingVision, Alkeus Pharmaceuticals, Kiora Pharmaceuticals, Nanoscope Therapeutics, 4D Molecular Therapeutics, Gensight Biologics, BioMarin Pharmaceutical Inc, Nightstar Therapeutics, MeiraGTx, Retinagenix Inc, Adverum Biotechnologies, AGTC Inc, Editas Therapeutics

Global Geographic Atrophy Market Trends and Insights

Major companies operating in the geographic atrophy market are focusing on innovative therapies such as complement inhibitor therapy to develop advanced treatments for geographic atrophy. Complement inhibitor therapy is a treatment that slows down an overactive immune response linked to certain diseases and helps protect healthy cells from damage and reduces disease progression. For instance, in February 2025, Astellas Pharma Inc., a Japan-based pharmaceutical company announced IZERVAY (avacincaptad pegol intravitreal solution) for geographic atrophy approved by the Food and Drug Administration, a US-based government agency. This approval allows IZERVAY to be used without a limitation on the duration of dosing for treating geographic atrophy (GA) secondary to age-related macular degeneration (AMD). This decision provides greater flexibility for managing GA, offering longer-term treatment options for both patients and healthcare providers.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Geographic Atrophy Market?

In January 2025, Bausch + Lomb Corporation, a US-based pharmaceutical and medical device company that specializes in eye health products, acquired Whitecap Biosciences LLC for an undisclosed amount. With this acquisition, Bausch + Lomb aims to expand its portfolio of innovative eye health solutions by incorporating Whitecap Biosciences' expertise in advanced ocular therapeutics. Whitecap Biosciences LLC is a US-based pharmaceutical company that specializes in developing novel therapies for ophthalmic diseases including geographic atrophy.

Regional Outlook

North America was the largest region in the geographic atrophy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Geographic Atrophy Market?

The geographic atrophy market consists of revenues earned by entities by providing gene therapies, and stem cell therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The geographic atrophy market also includes sales of artificial retinas, and medication. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Geographic Atrophy Market Report 2026?

The geographic atrophy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the geographic atrophy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Geographic Atrophy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.4 billion
Revenue Forecast In 2035	$3.92 billion
Growth Rate	CAGR of 13.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Type, Diagnosis, Route Of Administration, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Regeneron Pharmaceuticals Inc, Ocugen Inc, Kodiak Sciences Inc, Apellis Pharmaceuticals Inc, Iveric Bio, Graybug Vision, SparingVision, Alkeus Pharmaceuticals, Kiora Pharmaceuticals, Nanoscope Therapeutics, 4D Molecular Therapeutics, Gensight Biologics, BioMarin Pharmaceutical Inc, Nightstar Therapeutics, MeiraGTx, Retinagenix Inc, Adverum Biotechnologies, AGTC Inc, Editas Therapeutics
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Geographic Atrophy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Geographic Atrophy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Geographic Atrophy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Geographic Atrophy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Development Of Complement Inhibitor Therapies

4.2.2 Growing Focus On Early Diagnosis Of Retinal Disorders

4.2.3 Increased Investment In Novel Ophthalmic Drugs

4.2.4 Expansion Of Imaging Technologies For Disease Monitoring

4.2.5 Growing Clinical Trials For Amd Treatments

5. Geographic Atrophy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Ophthalmology Clinics

5.3 Eye Specialty Centers

5.4 Diagnostic Imaging Centers

5.5 Research Institutes

6. Geographic Atrophy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Geographic Atrophy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Geographic Atrophy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Geographic Atrophy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Geographic Atrophy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Geographic Atrophy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Geographic Atrophy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Geographic Atrophy Market Segmentation

9.1. Global Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, Complement Inhibitors, Neuroprotective Agents, Other Drug Types

9.2. Global Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fundus Autofluorescence (FAF), Optical Coherence Tomography Angiography (OCT-A), Multifocal Electroretinography (mfERG)

9.3. Global Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravitreal, Oral, Other Routes Of Administration

9.4. Global Geographic Atrophy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

9.5. Global Geographic Atrophy Market, Sub-Segmentation Of Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ranibizumab, Aflibercept, Bevacizumab

9.6. Global Geographic Atrophy Market, Sub-Segmentation Of Complement Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pegcetacoplan, Lfg316

9.7. Global Geographic Atrophy Market, Sub-Segmentation Of Neuroprotective Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Latanoprost, Brimonidine

9.8. Global Geographic Atrophy Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Steroids, Retinoids, Combination Therapy

10. Geographic Atrophy Market Regional And Country Analysis

10.1. Global Geographic Atrophy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Geographic Atrophy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Geographic Atrophy Market

11.1. Asia-Pacific Geographic Atrophy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Geographic Atrophy Market

12.1. China Geographic Atrophy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Geographic Atrophy Market

13.1. India Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Geographic Atrophy Market

14.1. Japan Geographic Atrophy Market Overview

14.2. Japan Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Geographic Atrophy Market

15.1. Australia Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Geographic Atrophy Market

16.1. Indonesia Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Geographic Atrophy Market

17.1. South Korea Geographic Atrophy Market Overview

17.2. South Korea Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Geographic Atrophy Market

18.1. Taiwan Geographic Atrophy Market Overview

18.2. Taiwan Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Geographic Atrophy Market

19.1. South East Asia Geographic Atrophy Market Overview

19.2. South East Asia Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Geographic Atrophy Market

20.1. Western Europe Geographic Atrophy Market Overview

20.2. Western Europe Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Geographic Atrophy Market

21.1. UK Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Geographic Atrophy Market

22.1. Germany Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Geographic Atrophy Market

23.1. France Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Geographic Atrophy Market

24.1. Italy Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Geographic Atrophy Market

25.1. Spain Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Geographic Atrophy Market

26.1. Eastern Europe Geographic Atrophy Market Overview

26.2. Eastern Europe Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Geographic Atrophy Market

27.1. Russia Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Geographic Atrophy Market

28.1. North America Geographic Atrophy Market Overview

28.2. North America Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Geographic Atrophy Market

29.1. USA Geographic Atrophy Market Overview

29.2. USA Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Geographic Atrophy Market

30.1. Canada Geographic Atrophy Market Overview

30.2. Canada Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Geographic Atrophy Market

31.1. South America Geographic Atrophy Market Overview

31.2. South America Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Geographic Atrophy Market

32.1. Brazil Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Geographic Atrophy Market

33.1. Middle East Geographic Atrophy Market Overview

33.2. Middle East Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Geographic Atrophy Market

34.1. Africa Geographic Atrophy Market Overview

34.2. Africa Geographic Atrophy Market, Segmentation By Drug Type, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Geographic Atrophy Market Regulatory and Investment Landscape

36. Geographic Atrophy Market Competitive Landscape And Company Profiles

36.1. Geographic Atrophy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Geographic Atrophy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Geographic Atrophy Market Company Profiles

36.3.1. Regeneron Pharmaceuticals Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Ocugen Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Kodiak Sciences Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Apellis Pharmaceuticals Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Iveric Bio Overview, Products and Services, Strategy and Financial Analysis

37. Geographic Atrophy Market Other Major And Innovative Companies

Graybug Vision, SparingVision, Alkeus Pharmaceuticals, Kiora Pharmaceuticals, Nanoscope Therapeutics, 4D Molecular Therapeutics, Gensight Biologics, BioMarin Pharmaceutical Inc, Nightstar Therapeutics, MeiraGTx, Retinagenix Inc, Adverum Biotechnologies, AGTC Inc, Editas Medicine, Editas Therapeutics

38. Global Geographic Atrophy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Geographic Atrophy Market

40. Geographic Atrophy Market High Potential Countries, Segments and Strategies

40.1 Geographic Atrophy Market In 2030 - Countries Offering Most New Opportunities

40.2 Geographic Atrophy Market In 2030 - Segments Offering Most New Opportunities

40.3 Geographic Atrophy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Geographic Atrophy Market, Overview Of Key Products - Product Examples

Table 2: Global Geographic Atrophy Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Geographic Atrophy Market, Supply Chain Analysis

Table 4: Global Geographic Atrophy Market, Major Raw Material Providers

Table 5: Global Geographic Atrophy Market, Major Resource Providers

Table 6: Global Geographic Atrophy Market, Major Manufacturers (Suppliers)

Table 7: Global Geographic Atrophy Market, Major Distributors And Channel Partners

Table 8: Global Geographic Atrophy Market, Key Technologies & Future Trends

Table 9: Global Geographic Atrophy Market, Major Trends

Table 10: Global Geographic Atrophy Market, Major End Users

Table 11: Global Geographic Atrophy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Geographic Atrophy Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Geographic Atrophy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Geographic Atrophy Market - TAM, US$ Billion, 2025

Table 15: Global Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Geographic Atrophy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Geographic Atrophy Market, Sub-Segmentation Of Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Geographic Atrophy Market, Sub-Segmentation Of Complement Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Geographic Atrophy Market, Sub-Segmentation Of Neuroprotective Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Geographic Atrophy Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Geographic Atrophy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Geographic Atrophy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Geographic Atrophy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Geographic Atrophy Market - Company Scoring Matrix

Table 99: Regeneron Pharmaceuticals Inc Financial Performance

Table 100: Ocugen Inc Financial Performance

Table 101: Kodiak Sciences Inc Financial Performance

Table 102: Apellis Pharmaceuticals Inc Financial Performance

Table 103: Iveric Bio Financial Performance

Table 104: Global Geographic Atrophy Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Geographic Atrophy Market, Competitive Dashboard

Table 106: Global Geographic Atrophy Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Geographic Atrophy Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Table 108: Global, Geographic Atrophy Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Table 109: Global, Geographic Atrophy Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Geographic Atrophy Market, Overview Of Key Products - Product Examples

Figure 2: Global Geographic Atrophy Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Geographic Atrophy Market, Supply Chain Analysis

Figure 4: Global Geographic Atrophy Market, Major Raw Material Providers

Figure 5: Global Geographic Atrophy Market, Major Resource Providers

Figure 6: Global Geographic Atrophy Market, Major Manufacturers (Suppliers)

Figure 7: Global Geographic Atrophy Market, Major Distributors And Channel Partners

Figure 8: Global Geographic Atrophy Market, Key Technologies & Future Trends

Figure 9: Global Geographic Atrophy Market, Major Trends

Figure 10: Global Geographic Atrophy Market, Major End Users

Figure 11: Global Geographic Atrophy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Geographic Atrophy Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Geographic Atrophy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Geographic Atrophy Market - TAM, US$ Billion, 2025

Figure 15: Global Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Geographic Atrophy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Geographic Atrophy Market, Sub-Segmentation Of Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Geographic Atrophy Market, Sub-Segmentation Of Complement Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Geographic Atrophy Market, Sub-Segmentation Of Neuroprotective Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Geographic Atrophy Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Geographic Atrophy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Geographic Atrophy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Geographic Atrophy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Geographic Atrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Geographic Atrophy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Geographic Atrophy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Geographic Atrophy Market - Company Scoring Matrix

Figure 99: Regeneron Pharmaceuticals Inc Financial Performance

Figure 100: Ocugen Inc Financial Performance

Figure 101: Kodiak Sciences Inc Financial Performance

Figure 102: Apellis Pharmaceuticals Inc Financial Performance

Figure 103: Iveric Bio Financial Performance

Figure 104: Global Geographic Atrophy Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Geographic Atrophy Market, Competitive Dashboard

Figure 106: Global Geographic Atrophy Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Geographic Atrophy Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Figure 108: Global, Geographic Atrophy Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Figure 109: Global, Geographic Atrophy Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Homeopathy Market Report 2026 - Global Outlook – By Type (Dilutions, Tinctures, Biochemics, Ointments, Tablets, Other Types), By Source (Plants, Animals, Minerals), By Distribution Channel (Homeopathic Clinics, Retailers...

Optic Atrophy Management Market Report 2026 - Global Outlook – By Drug Type (Disulfiram, Amebicides, Ethambutol, Isoniazid, Chloramphenicol, Vincristine, Ciclosporin, Cimetidine), By Route Of Administration (Oral, Inject...

Nootropics Market Report 2026 - Global Outlook – By Drug Type (Prescription Nootropics, Over-The-Counter (OTC) Nootropics), By Form (Capsules Or Tablets, Powder, Drinks, Other Forms), By Distribution Channel (Offline, On...

Geographic Information System Market Report 2026 - Global Outlook – By Component (Hardware, Software, Services), By Function (Mapping, Surveying, Telematics And Navigation, Location-Based Services), By Device (Desktop, M...

Geotourism Market Report 2026 - Global Outlook – By Tour Type (Individual Travel, Professional Groups, Group Travels), By Tourism Type (Sustainable Tourism, Urban Geo-Tourism, Rural Geo-Tourism, Natural Tourism, Eco Geo-...

Athleisure Market Report 2026 - Global Outlook – By Price Category (Mass, Premium), By Product (Yoga Apparels, Shirts, Leggings, Shorts, Other Products), By Distribution Channel (Online, Offline), By End User (Men, Women...

Geosynthetics Market Report 2026 - Global Outlook – By Type (Geotextiles, Geomembranes, Geogrids, Geofoam, Geonets, Other Types), By Material (Polyethylene, Polypropylene, Polyester, PVC, Other Materials), By Function (S...

Frequently Asked Questions

How big is the Geographic Atrophy Market?

The Geographic Atrophy market was valued at $2.11 billion in 2025, increased to $2.4 billion in 2026, and is projected to reach $3.92 billion by 2030.

What is the Geographic Atrophy market growth?

The global Geographic Atrophy market is expected to grow at a CAGR of 13.1% from 2026 to 2035 to reach $3.92 billion by 2035.

Who are the key players in Geographic Atrophy market?

Some Key Players in the Geographic Atrophy market Include, Regeneron Pharmaceuticals Inc, Ocugen Inc, Kodiak Sciences Inc, Apellis Pharmaceuticals Inc, Iveric Bio, Graybug Vision, SparingVision, Alkeus Pharmaceuticals, Kiora Pharmaceuticals, Nanoscope Therapeutics, 4D Molecular Therapeutics, Gensight Biologics, BioMarin Pharmaceutical Inc, Nightstar Therapeutics, MeiraGTx, Retinagenix Inc, Adverum Biotechnologies, AGTC Inc, Editas Therapeutics .

What is the anticipated growth trend for the Geographic Atrophy market?

Major trend in this market includes: Innovative Complement Inhibitor Therapy Advancing Treatment Options For Progressive Eye Disease. For further insights on this market. request a sample here

Which region has the most growth potential in the Geographic Atrophy market?

North America was the largest region in the geographic atrophy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the geographic atrophy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.